Adherence Core is a shared resource which supports the three intervention studies with behavioral components.
The aims of the shred resource are: 1) Promote participant adherence/compliance with fiber, piroxicam and DFMO trials, 2) Consult with and provide behavioral findings applicable to other Cores, 3) document the Health Behavior Profile for sensitivity in distinguishing among good, marginal and poor adherers, making necessary refinements, and 4) Identify factors associated with short and long-term adherence success and failure in the three representative cancer prevention and control trials with participants at risk for colon cancer, to identify potential predisposing factors for low adherence in Phase IV trials, 5) Identify the efficacy of the Health Behavior Profile-based adherence intervention. Subjects in the fiber (n 1000), piroxicam (n=100) and DFMO (n=100) trials are 40-80 year olds with a history of adenomatous polyps. Primarily correlational data are used. Also, a prospective case control strategy with a subsample of poor and marginal adherers matched with good adherer controls (n=81) is used to assess aim #4. Descriptive statistics, Harvey-Goldstein ML-2 analysis for aim #4 and an economic-based efficiency analysis for aim #5 will be performed. Core outcomes include adherence promotion, an efficiency estimate of the Health Behavior Profile-based intervention, a test of the effectiveness of the general and individualized interventions, and description of factors in adherence failure in preparation for Phase IV cancer prevention and control community-based trials with people at risk for colon cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA041108-05
Application #
3807439
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Arizona
Department
Type
DUNS #
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Lance, Peter; Alberts, David S; Thompson, Patricia A et al. (2017) Colorectal Adenomas in Participants of the SELECT Randomized Trial of Selenium and Vitamin E for Prostate Cancer Prevention. Cancer Prev Res (Phila) 10:45-54
Thompson, Patricia A; Ashbeck, Erin L; Roe, Denise J et al. (2016) Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes. J Natl Cancer Inst 108:
Jacobs, Elizabeth T; Haussler, Mark R; Alberts, David S et al. (2016) Association between Circulating Vitamin D Metabolites and Fecal Bile Acid Concentrations. Cancer Prev Res (Phila) 9:589-97
Liu, Lin; Messer, Karen; Baron, John A et al. (2016) A prognostic model for advanced colorectal neoplasia recurrence. Cancer Causes Control 27:1175-85
Thompson, Patricia A; Ashbeck, Erin L; Roe, Denise J et al. (2016) Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial. J Natl Cancer Inst 108:
Hibler, Elizabeth A; Sardo Molmenti, Christine L; Dai, Qi et al. (2016) Physical activity, sedentary behavior, and vitamin D metabolites. Bone 83:248-255
Hibler, Elizabeth A; Klimentidis, Yann C; Jurutka, Peter W et al. (2015) CYP24A1 and CYP27B1 Polymorphisms, Concentrations of Vitamin D Metabolites, and Odds of Colorectal Adenoma Recurrence. Nutr Cancer 67:1131-41
Minasian, Lori M; Tangen, Catherine M; Wickerham, D Lawrence (2015) Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program. Semin Oncol 42:748-63
Bea, Jennifer W; Jurutka, Peter W; Hibler, Elizabeth A et al. (2015) Concentrations of the vitamin D metabolite 1,25(OH)2D and odds of metabolic syndrome and its components. Metabolism 64:447-59
Molmenti, Christine L Sardo; Hibler, Elizabeth A; Ashbeck, Erin L et al. (2014) Sedentary behavior is associated with colorectal adenoma recurrence in men. Cancer Causes Control 25:1387-95

Showing the most recent 10 out of 149 publications